Literature DB >> 7504080

Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures.

M B Robinson1, S Djali, J R Buchhalter.   

Abstract

Sodium-dependent, high-affinity glutamate transport is generally assumed to limit the toxicity of glutamate in vivo and in vitro, but there is very little direct evidence to support this hypothesis. In the present study, the effects of the specific uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate on the toxicity and clearance of glutamate were examined in hippocampal neuronal cultures. At a concentration that was not toxic by itself, L-trans-pyrrolidine-2,4-dicarboxylate increased the toxicity of glutamate approximately fivefold and slowed the clearance of glutamate from the extracellular space. This toxicity was almost completely blocked by the N-methyl-D-aspartate receptor antagonist, D-2-amino-5-phosphonopentanoate. These studies provide direct evidence that sodium-dependent, high-affinity glutamate transport limits glutamate toxicity in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504080     DOI: 10.1111/j.1471-4159.1993.tb07447.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  15 in total

1.  NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Authors:  J D Sinor; S Du; S Venneti; R C Blitzblau; D N Leszkiewicz; P A Rosenberg; E Aizenman
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine.

Authors:  S Rosi; V Ramirez-Amaya; A Vazdarjanova; E E Esparza; P B Larkin; J R Fike; G L Wenk; C A Barnes
Journal:  Brain       Date:  2009-06-16       Impact factor: 13.501

Review 3.  The role of excitatory amino acid transporters in cerebral ischemia.

Authors:  Xiao-dong Chao; Fei Fei; Zhou Fei
Journal:  Neurochem Res       Date:  2010-05-04       Impact factor: 3.996

Review 4.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

5.  Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression.

Authors:  Susanna Rosi; Victor Ramirez-Amaya; Almira Vazdarjanova; Paul F Worley; Carol A Barnes; Gary L Wenk
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

6.  Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro.

Authors:  Melissa S Pathmajeyan; Sarjubhai A Patel; James A Carroll; Todd Seib; James F Striebel; Richard J Bridges; Bruce Chesebro
Journal:  Glia       Date:  2011-07-15       Impact factor: 7.452

7.  Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity.

Authors:  Ross D O'Shea; Melissa V Fodera; Karina Apricó; Yvette Dehnes; Niels C Danbolt; Duncan Crawford; Philip M Beart
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

8.  Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.

Authors:  Geraldine T Petr; Laurel A Schultheis; Kayla C Hussey; Yan Sun; Janet M Dubinsky; Chiye Aoki; Paul A Rosenberg
Journal:  Eur J Neurosci       Date:  2013-04-16       Impact factor: 3.386

Review 9.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.